Cytokine markers of the efficiency of correction of oxidative stress in patients with limited sclerodermia
Year: 2015, volume 11 Issue: №3 Pages: 410-414
Heading: Dermatovenerology Article type: Short message
Authors: Tlish M.M., Sorokina N.V.
Organization: Kuban State Medical University
Heading: Dermatovenerology Article type: Short message
Authors: Tlish M.M., Sorokina N.V.
Organization: Kuban State Medical University
Summary:
Objective: to improve treatment of patients with limited sclerodermia (LSD) by increasing efficiency and reducing the time of their treatment. Material and methods. The examination and treatment of 52 patients with circumscribed scleroderma were conducted. Two groups of these patients were formed with method of adaptive randomization. In the control group complex treatment was underwent according to the standards in this nosology. In the general group the patients additionally received antioxidant therapy. The course of treatment was 21 days in both groups. Results. Treatment results were evaluated in accordance with the dynamics of cutaneous pathological process and cytokine profile. In the course of treatment positive clinical dynamics in patients of the study group went faster and was accompanied by a more pronounced reduction in inflammatory activity in the blood serum. Conclusion. The results suggest that antioxidant therapy improves the efficiency and reduces the treatment time of patients with circumscribed sclerodermia.
Bibliography:
1. Dacczak-Pazdrowska A, Kowalczyk M, Szramka-Pawlak B, Gornowicz-Porowska J, etal. Clinical research lnterleukin-17A and interleukin-23 in morphea / Arch Med Sci 2012; 8 (6): 1089-1095 DOI (digital object identifier): 10.5114/aoms.2012.32421
2. Kreuter A, Krieg T, Worm M, et al. Diagnosis and therapy of localized scleroderma. J Deutsch Dermatol Ges 2009; 7 (suppl. 6): S1-14
3. Xie Y, Zhang X, Wakasugi S, Makino T, Inoue Y, Ihn H. Im-munohistochemical characterization of the cellular infiltrate in localized scleroderma. Int J Dermatol 2008; 47: 438-42
4. Dziankowska-Bartkowiak B, Gerlicz-Kowalczuk Z, Waszczykowska E. Angiogenin and SDF-1 alpha serum concentration in patients with systemie sclerosis: In relation to clinical status. Arch Med Sci 2011; 7: 92-96
5. Carolyn A., Bangert, Kim A, Jacobe H. Localized Sclero-derma. In: MayesMD (ed.) A Visual Guide to scleroderma and approach to Treatment Springer. DOI 10.1007/978-1-4939-0980-3. Science+Business Media New York, 2014; p. 5-21
6. Hatomochi A, Ono M, Arakawa M, et al. Analysis of collagen gene expression by cultured fibroblasts in morphea. Br J Dermatol 1992; 126:216-221
7. Scharffetter Kochanek K, Goldermann R, Lehmann P, et al. PUVA therapy in disabling pansclerotic morphea of children. Br J Dermatol 1995; 132: 830-831
8. El-Mofty M, Zaher H, Basseila M. Low dose broad-band UVA in morphea using a new method for evaluation. Photoder-matol Photoimmunol Photomed 2000; 16: 43-49. DOI: 10.1034/ j.1600-0781.2000.d01 -1.x
9. Mayes MD, Lacey JV Jr, Beebe-Dimmer J, et al. Prevalence, incidence, survival and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003; 48: 2246-2255
10. Yagoda AV, Gladkikh NN. Autoimmune aspects of collagen homeostasis disorder in undifferentiated connective tissue dysplasia. Medical immunology 2007; 9 (1): 61-68
11. Kozlov VA, Sennikova SV. The system of cytokines. Novosibirsk: Nauka, 2004; 324 p.
12. Kalinina ЕР, Ivanov ЕМ, Isachenko EG. Violations of in-tersystem interactions in chronic inflammatory process. Medical immunology 2007; 9 (6): 581
13. Abbas АК, Lichtman АН. Basic Immunology 2-ed. Else-vier, 2004; 322 p.
14. Ivanov AA, Smooth OP, Kuznetsova AV, Danilova Tl. Intercellular and cell-matrix interaction in pathology. Molecular medicine 2005; 2: 16-21
15. Sambo Р, Baroni SS, Luchetti М, et al. Oxidative stress in scleroderma: Maintenance of scleroderma fibroblast phenotype by the constitutive upregulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum 2001; 44: 2653-2664.
| Attachment | Size |
|---|---|
| 2015_03-01_410-414.pdf | 610.32 KB |
Русский
English